HeartSciences (NASDAQ:HSCS) had its price target raised by analysts at Ascendiant Capital Markets from $9.00 to $9.20. They now have a "buy" rating on the stock.
Heart Test Laboratories reports Q2 results [Seeking Alpha]
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 [Yahoo! Finance]